Karya Bersama Anugerah Tbk. vs Merck Tbk. — how do they compare? Karya Bersama Anugerah Tbk. trades at Rp40 (market cap 314.6B, 7.88M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 5.4× Karya Bersama Anugerah Tbk.'s market cap, and Karya Bersama Anugerah Tbk. is more actively traded (7.88M versus 37.6K). Which is the better fit depends on your goals.
| KBAG | MERK | |
|---|---|---|
Market Cap | 314.6B | 1.7T |
Volume | 7.88M | 37.6K |
Lot | 78.8K | 376 |
Turnover | 318.82M | 144.47M |
Average Price | 40.46 | 3,842.23 |
Value | 318.82M | 144.47M |
Indicative Equilibrium Price | 40 | 3,840 |
Indicative Equilibrium Volume | 3.2K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Karya Bersama Anugerah Tbk (Company) was established based on Deed No.39, dated February 14, 2014 made by Andreas Gunawan, SH.,M.Kn., notary in Balikpapan.
Read more on KBAG →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →